ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
0.386
-0.017 (-4.22%)
Feb 21, 2025, 4:00 PM EST - Market closed
ImmunoPrecise Antibodies Market Cap
ImmunoPrecise Antibodies has a market cap or net worth of $12.95 million as of February 21, 2025. Its market cap has decreased by -78.57% in one year.
Market Cap
12.95M
Enterprise Value
22.20M
1-Year Change
-78.57%
Ranking
Category
Stock Price
$0.39
Market Cap Chart
Since December 31, 2020, ImmunoPrecise Antibodies's market cap has decreased from $250.60M to $12.95M, a decrease of -94.83%. That is a compound annual growth rate of -51.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 10.50M | -6.25% |
| Dec 31, 2024 | 11.20M | -73.83% |
| Dec 29, 2023 | 42.80M | -67.05% |
| Dec 30, 2022 | 129.90M | 25.14% |
| Dec 31, 2021 | 103.80M | -58.58% |
| Dec 31, 2020 | 250.60M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |